Key facts
- This page summarizes Charles B. O'Keeffe's Form 4 filing for CATALYST PHARMACEUTICALS, INC. (CPRX).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 11 Dec 2024, 17:00.
Charles B. O'Keeffe - 09 Dec 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)
- Reporting relationship
- Director
- Issuer ticker
- CPRX
- Reported as of
- 09 Dec 2024
- Net transaction value
- +$160,400
- SEC form
- 4
- Accepted by SEC
- 11 Dec 2024, 17:00:19 UTC
- Prior SEC filing
- 25 Nov 2024
- Next SEC filing
- 31 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Charles B. O'Keeffe
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Charles B. O'Keeffe filed Form 4 for CATALYST PHARMACEUTICALS, INC. (CPRX) on 11 Dec 2024.
Change
- Previous filing in this sequence was filed on 25 Nov 2024.
- Current net transaction value: +$160,400.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CPRX
transaction
Common Stock, par value $0.001 per share
Options Exercise
- Transaction value
- Shares
- +1,413
- Change %
- +0.21%
- Price
- Shares after
- 687,137
- Date
- 09 Dec 2024
- Ownership
- Direct
- Footnotes
- F1
CPRX
transaction
Common Stock, par value $0.001 per share
Options Exercise
- Transaction value
- $160,400
- Shares
- +40,000
- Change %
- +5.8%
- Price
- $4.01
- Shares after
- 727,137
- Date
- 10 Dec 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CPRX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,413
- Change %
- -0.55%
- Price
- $0.000000
- Shares after
- 253,607
- Date
- 09 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,413
- Exercise price
- Footnotes
- F1, F2, F3
CPRX
transaction
Derivative
Options to purchase common stock
Options Exercise
- Transaction value
- $0
- Shares
- -40,000
- Change %
- -16%
- Price
- $0.000000
- Shares after
- 213,607
- Date
- 10 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $4.01
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
Footnote F2
Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026.
Footnote F3
Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 9, 2024.
Footnote F4
Options vested in three annual tranches beginning on January 2, 2019.